Benzene as a leukemogenic and carcinogenic agent.

Area of Science:

• Toxicology
• Oncology
• Hematology

Background:

• Benzene is a known industrial solvent with widespread human exposure.
• Evidence suggests a causal link between benzene and hematologic malignancies.
• Bone marrow depression is a significant health concern associated with benzene exposure.

Purpose of the Study:

• To review and discuss the carcinogenic potential of benzene.
• To examine the association between benzene and specific cancers like leukemia, lymphoma, and lung cancer.
• To explore the role of individual susceptibility in benzene-induced disorders.

Main Methods:

• Literature review of existing toxicological and epidemiological data.
• Analysis of studies investigating benzene exposure and cancer incidence.
• Discussion of mechanisms underlying benzene's hematotoxicity.

Main Results:

• Benzene is strongly implicated as a potent carcinogen.
• Leukemia, malignant lymphoma, multiple myeloma, and lung cancer are associated with benzene exposure.
• Benzene exposure can lead to various bone marrow disorders.

Conclusions:

• Sufficient data incriminates benzene as a significant carcinogenic agent.
• Genetic and individual factors may modulate the risk of benzene-related malignancies.
• Further discussion of these issues is warranted based on current data.